guest ::
| Home > Publications database > Direct optimization of the probability of lesion origin in proton treatment planning for low-grade glioma patients. |
| Home > Publications database > Direct optimization of the probability of lesion origin in proton treatment planning for low-grade glioma patients. |
| Journal Article | DKFZ-2026-00789 |
; ; ; ; ; ;
2026
Wiley
Hoboken, NJ
Abstract: In proton therapy of low-grade glioma (LGG) patients, contrast-enhancing brain lesions (CEBLs) on magnetic resonance imaging are considered predictive of late radiation-induced lesions. From the observation that CEBLs tend to concentrate in regions of increased dose-averaged linear energy transfer (LETd) and proximal to the ventricular system, the probability of lesion origin (POLO) model has been established as a multivariate logistic regression model for the voxel-wise probability prediction of the CEBL origin.To date, leveraging the predictive power of the POLO model for treatment planning relies on hand tuning the dose and LETd distribution to minimize the resulting probability predictions. In this paper, we therefore propose automated POLO model-based treatment planning by directly integrating POLO calculation and optimization into plan optimization for LGG patients.We introduce an extension of the original POLO model including a volumetric correction factor, and a model-based optimization scheme featuring a linear reformulation of the model together with feasible optimization functions based on the predicted POLO values. The developed framework is implemented in the open-source treatment planning toolkit matRad.Our framework can generate clinically acceptable treatment plans while automatically taking into account outcome predictions from the POLO model. It also supports the definition of customized POLO model-based objective and constraint functions. Optimization results from a sample LGG patient show that the POLO model-based outcome predictions can be minimized under expectable shifts in dose, LETd, and POLO distributions, while sustaining target coverage ( Δ PTV D95 RBE , fx ≈ 0.00 ${{\Delta}}_{\text{PTV}}{\text{D95}}_{\textit{RBE},\textit{fx}}\approx 0.00$ , Δ GTV D95 RBE , fx ≈ 0.03 ${{\Delta}}_{\text{GTV}}{\text{D95}}_{\textit{RBE},\textit{fx}}\approx 0.03$ ), even when NTCP is strongly downregulated.POLO model-based treatment plan optimization for LGG patients can be implemented in a technically feasible way, alleviating the need to hand tune the dose and LETd distribution. Future work should address multipatient follow-up studies.
Keyword(s): Glioma: radiotherapy (MeSH) ; Glioma: pathology (MeSH) ; Glioma: diagnostic imaging (MeSH) ; Radiotherapy Planning, Computer-Assisted: methods (MeSH) ; Humans (MeSH) ; Proton Therapy: adverse effects (MeSH) ; Probability (MeSH) ; Brain Neoplasms: radiotherapy (MeSH) ; Brain Neoplasms: diagnostic imaging (MeSH) ; Brain Neoplasms: pathology (MeSH) ; Neoplasm Grading (MeSH) ; Radiotherapy Dosage (MeSH) ; Magnetic Resonance Imaging (MeSH) ; outcome‐based treatment planning ; proton therapy ; voxel‐based outcome analysis
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
